Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287958 · ClinicalTrials.gov registry record
Feasibility of an Electrical Impedance Tomography Device for Pulmonary Function Testing in ALS Patients
A clinical trial of ALS, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 58
- Enrollment target
- 2
- Study locations
NCT05287958: Completed study of ALS, sponsored by Beth Israel Deaconess Medical Center.
NCT05287958 is a study of ALS that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 58 participants, below the 1,034-participant average among 19 other ALS trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287958, a study of ALS, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an unblinded pilot study to investigate the technical feasibility of using an electrical impedance tomography device for noninvasive pulmonary function monitoring in ALS patients. The study will enroll patients with ALS in one cohort and healthy volunteers in a second cohort that will both undergo EIT imaging with the investigational device prior to and while performing a standard PFT procedure.
Primary Outcome
A correlation coefficient (-1 to +1) will be used
Conditions Studied
Interventions
- DIAGNOSTIC_TEST EIT
Study Locations (2)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2023-09-20 |
What the finished NCT05287958 record still lists
NCT05287958 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,034-participant average among 19 other ALS trials with a reported enrollment target (94% lower).
The record links to 1 condition, with ALS appearing as the primary indexed condition, and to 1 intervention - of which EIT is the first listed.
NCT05287958 reports a single indexed study location in Massachusetts, New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05287958 about?
NCT05287958 is a clinical study titled "Feasibility of an Electrical Impedance Tomography Device for Pulmonary Function Testing in ALS Patients". This is an unblinded pilot study to investigate the technical feasibility of using an electrical impedance tomography device for noninvasive pulmonary function monitoring in ALS patients. The study will enroll patients with ALS in one cohort and healthy volunteers in a second cohort that will both u...
What is the current status of trial NCT05287958?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2021-07-15. Estimated completion is 2023-09-20.
What conditions does trial NCT05287958 study?
This clinical trial studies the following conditions: ALS.
What interventions are being tested in trial NCT05287958?
The interventions under investigation include: EIT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05287958?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287958 being conducted?
This trial has 2 study locations across Massachusetts, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ALS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05287958's enrollment target sits among peer trials
58 11th of 19 higher than 9 of 19 other ALS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ALS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ALS/MND Natural History Study Data Repository
RECRUITING
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
RECRUITING · Phase 1
-
Amyotrophic Lateral Sclerosis (ALS) Families Project
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
RECRUITING · NA
-
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI